Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Novo Nordisk Partners with BE&K for Facility Expansion in Clayton, NC | Contract Pharma

What are you searching for?

Sign in
Breaking News

Novo Nordisk Partners with BE&K for Facility Expansion in Clayton, NC

The project will involve the construction of 10 or more buildings and multi-building combinations, providing more than 1.4 million square feet.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

BE&K Building Group (BE&K), a design-build and construction management firm, has partnered with global healthcare leader Novo Nordisk to manage a new multi-product facility adjacent to Novo Nordisk’s existing operations in Clayton, North Carolina.​

The project will involve the construction of ten or more buildings and multi-building combinations, providing more than 1.4 million square feet.

BE&K will directly perform a significant portion of the work as Construction Manager and will serve as the Agency Construction Manager for the remainder of the work, providing oversight for the development of the facility that will span approximately 56 acres. The final facility will be instrumental in manufacturing Novo Nordisk’s treatments for obesity and other chronic diseases.

“Clayton was the first manufacturing site for Novo Nordisk in the US, and this new, large-scale investment here confirms the continued importance of our production facilities in North Carolina. We are proud to be one of the cornerstones of our company’s growth,” said Niels Laurbjerg Nielsen, Corporate Vice President, Novo Nordisk. “For decades, we’ve partnered to foster a well-trained, dedicated and diverse local workforce here. We are one team driven by one purpose: to deliver more for the millions of people living with chronic diseases – and we will achieve that with this facility.”

Construction will gradually be finalized between 2027 and 2029.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics